Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-13

Clinical Trial Update: Stroke and Tocotrienol: Unique Role in Neuroprotection [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update examining the neuroprotective role of tocotrienol in ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tocotrienol (tocotrienol (vitamin E) supplement)

Snippet

Sponsor: Seberang Jaya Clinical Research Centre | Conditions: Ischemic Stroke | Phase 3 | Status: UNKNOWN